Antibody molecules which bind CD22
US12331117B2 · kind B2 · utility
0Cited by
99References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Aug 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compositions in treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.